New products, studies could make intrauterine birth control devices more popular
Intrauterine devices, or IUDs, are considered a highly effective contraceptive device and more convenient than a once-a-day birth control pill. New products and studies currently underway may make them even more popular in the years to come, according to RH
Recent actions call into question whether Fresenius cares about patient safety
Recent actions by Fresenius Medical Care suggest the world’s largest provider of dialysis products and services may not be too concerned about patient safety.
FDA sends warning letter to Endo following inspection at its transvaginal mesh plant
Endo International received a warning letter from the Food and Drug Administration (FDA) regarding unresolved problems previously identified during an inspection at its American Medical Systems (AMS) facility, which manufactures transvaginal mesh. The company’s mesh implants have been the subject
FDA advises doctors that a type of laproscopic surgery can spread uterine cancer
Doctors should stop using power morcellators to remove uterine growths, or fibroids, in women’s abdomens because doing so increases the risk of spreading cancer, the Food and Drug Administration (FDA) advised.
Repros enrolls men to test new topical testosterone treatment Androxal
Repros Therapeutics Inc. announced it has completed enrollment for one of two clinical trials pitting its topical testosterone gel alternative Androxal against other topical testosterone products currently on the market.
Many cardiologists reluctant to follow new guidelines for cholesterol-lowering statins
Not all cardiologists agree with or plan to adhere to new guidelines that support more liberal use of cholesterol-lowering statins, such as Lipitor and Zocor, among more populations of patients, according to comments made by cardiologists last week at the
FDA approves new type 2 diabetes drug Tanzeum
After a three-month delay, the Food and Drug Administration (FDA) has approved GlaxoSmithKline’s new type 2 diabetes treatment, albiglutide. The drug will be marketed in the United States as Tanzeum.
Study: Low T contributes to more satisfying relationships
Low testosterone levels in men have been blamed for a variety of symptoms – from low sex drive and mood swings to weight gain and muscle loss. But a new study shows that low testosterone has its benefits. It may actually
Cases of diabetes on the rise in the United States
The number of Americans with diabetes has nearly doubled in the past 20 years, paralleling the country’s growing obesity epidemic. Experts say if the trend continues, the number of Americans with diabetes will reach 44 million in the next 20
Federal judge blocks Massachusetts ban of new painkiller Zohydro
Drug maker Zogenix Inc., won another battle in its war to get its controversial painkiller Zohydro on the market. This week, a Massachusetts federal judge blocked plans by Massachusetts Gov. Deval Patrick to ban prescriptions and sales of the newly